Familial Combined Hyperlipidemia Latest Advances

Find the Latest Research About Familial Combined Hyperlipidemia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 792 publications

Decoding Primary Hyperlipoproteinemias: A Focus on the Pathogenesis and Diagnosis of Familial Hypercholesterolemia and Familial Combined Hyperlipidemia.

Decoding Primary Hyperlipoproteinemias: A Focus on the Pathogenesis and Diagnosis of Familial Hypercholesterolemia and Familial Combined Hyperlipidemia.

Journal: Diagnostics (Basel, Switzerland)
Published: May 26, 2026

A Case of Diabetes With a Rare Variant of Familial Combined Hyperlipidemia With an Atypical Phenotype.

A Case of Diabetes With a Rare Variant of Familial Combined Hyperlipidemia With an Atypical Phenotype.

Journal: Cureus
Published: June 02, 2025

Familial Combined Hyperlipidemia: Myth or Reality?

Familial Combined Hyperlipidemia: Myth or Reality?

Journal: Current atherosclerosis reports
Published: March 09, 2025

Lipoprotein(a) in familial dyslipidemias: The effect on cardiovascular prognosis in patients with familial hypercholesterolemia or familial combined hyperlipidemia.

Lipoprotein(a) in familial dyslipidemias: The effect on cardiovascular prognosis in patients with familial hypercholesterolemia or familial combined hyperlipidemia.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: October 13, 2024

Evaluating Dyslipidemia and Atherogenic Indices as Predictors of Coronary Artery Disease Risk: A Retrospective Cross-Sectional Study.

Evaluating Dyslipidemia and Atherogenic Indices as Predictors of Coronary Artery Disease Risk: A Retrospective Cross-Sectional Study.

Journal: Cureus
Published: October 07, 2024

Interaction Between Primary Hyperlipidemias and Type 2 Diabetes: Therapeutic Implications.

Interaction Between Primary Hyperlipidemias and Type 2 Diabetes: Therapeutic Implications.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: June 07, 2024

Identification of tacrolimus-related genes in familial combined hyperlipidemia and development of a diagnostic model using bioinformatics analysis.

Identification of tacrolimus-related genes in familial combined hyperlipidemia and development of a diagnostic model using bioinformatics analysis.

Journal: Heliyon
Published: April 27, 2024

A novel mouse model of familial combined hyperlipidemia and atherosclerosis.

A novel mouse model of familial combined hyperlipidemia and atherosclerosis.

Journal: Acta pharmacologica Sinica
Published: December 05, 2023

The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study.

The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study.

Journal: Journal of endocrinological investigation
Published: November 22, 2023

Performance of the enhanced Sampson-NIH equation for VLDL-C and LDL-C in a population with familial combined hyperlipidemia.

Performance of the enhanced Sampson-NIH equation for VLDL-C and LDL-C in a population with familial combined hyperlipidemia.

Journal: Atherosclerosis
Published: July 24, 2023

Lipoprotein(a), metabolic profile and new-onset type 2 diabetes in patients with familial combined hyperlipidemia: A 9 year follow-up study.

Lipoprotein(a), metabolic profile and new-onset type 2 diabetes in patients with familial combined hyperlipidemia: A 9 year follow-up study.

Journal: Journal of clinical lipidology
Published: January 12, 2023

The clinical utility of polygenic risk scores for combined hyperlipidemia.

The clinical utility of polygenic risk scores for combined hyperlipidemia.

Journal: Current opinion in lipidology
Published: January 05, 2023
Showing 1-12 of 792

Last Updated: 09/26/2026